Corporate Board Profile
Tech Score: 25/100
1 mention(s) identify CLAIRE M. FRASER, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| BECTON DICKINSON & CO | 2024-12-19 | Dr. Fraser is an internationally recognized scientist who contributes to the Board a strong background in genomics, infectious diseases and molecular diagnostics. | Has a strong background in genomics and molecular diagnostics, which involves significant technical expertise. |
| Filing Date | Source Excerpt |
|---|---|
| 2021-12-16 | Claire M. Fraser, Ph.D. | 66Director, Institute for Genome Sciences Director Since:2006 Independent:Yes Committees: Science, Marketing, Innovation and Technology (Chair), Corporate Governance and Nominating, Quality and Regulatory. Non-management director compensation table shows total compensation of $346,172. |
| 2022-12-15 | Claire M. Fraser, Ph.D. | 67Director, Institute for Genome Sciences...Independent:Yes...Committees: Compensation and Human Capital, Quality and Regulatory...Fiscal 2022 director compensation: Claire M. Fraser 347,580 |
| 2023-12-14 | Claire M. Fraser, Ph.D. | 68 Founding Director, Institute for Genome Sciences Director Since: 2006 Independent: Yes Committees: Compensation and Human Capital, Corporate Governance and Nominating Fiscal 2023 director compensation: Total 340,153 |
| 2024-12-19 | Dr. Fraser is an internationally recognized scientist who contributes to the Board a strong background in genomics, infectious diseases and molecular diagnostics. |
Data sourced from SEC filings. Last updated: 2025-07-01